⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
INO News
Inovio Pharmaceuticals, Inc.
INOVIO Announces Pricing of $20.0 Million Public Offering
prnewswire.com
INO
Form 8-K
sec.gov
INO
INOVIO Announces Proposed Public Offering
prnewswire.com
INO
Correction: Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight
globenewswire.com
JNJ
BNTX
GMAB
IMUX
INO
PDSB
AZN
GSK
MRK
BIIB
EXEL
REGN
CUE
IOBT
RAPT
PRE
Phase II Trial of Cadonilimab(PD-1/CTLA-4) Combination Regimen Launches in the United States for Perioperative Treatment of Gastric Cancer
prnewswire.com
INO
Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight
globenewswire.com
JNJ
BNTX
CUE
GMAB
IMPP
INO
AZN
GSK
MRK
BMY
EXEL
REGN
PDSB
IOVA
RPTX
Battery-Free: VidaBay Snap Passive E Ink Instant Film Turns Mobile Album Photos Into Displayable, Giftable Home Decor
prnewswire.com
INO
Kuehn Law Encourages Investors of Inovio Pharmaceuticals, Inc. to Contact Law Firm
prnewswire.com
INO
Lifshitz Law PLLC Announces Investigations of BlackRock, TCP Capital Corp. (NASDAQ: TCPC), Oracle Corporation (NYSE: ORCL), REGENXBIO Inc. (NASDAQ: RGNX), and Inovio Pharmaceuticals, Inc. (NASDAQ: INO)
accessnewswire.com
TCPC
ORCL
RGNX
INO
Kuehn Law Encourages Investors of Inovio Pharmaceuticals, Inc. to Contact Law Firm
globenewswire.com
INO